The aim of this research was to study the parameters of fetal ultrasound imaging and Doppler ultrasound study in pregnant women with extragenital diseases (EGDs) during the treatment regimes with and without hyperbaric oxygen therapy (HBOT). Materials and Methods: A total of 235 pregnant women were examined prospectively at 5 to 40 weeks of gestation. The main group included 191 women with EGDs (anemia, arterial hypertension, chronic pyelonephritis); the control group included 44 women with physiological pregnancy without EGDs. Evaluation of treatment efficacy was based on data from clinical and laboratory findings before treatment and after its completion. The following hardware methods of research were performed: ultrasonography, fetometry, dopplerometric study of fetoplacental complex. Results: Based on data obtained from this study, the following findings were made:-In the early stages of gestation, there were no disturbances in fetoplacental blood circulation.-Starting the 19th week of pregnancy, there is a significant increase in the uterine artery resistive index in pregnant women with arterial hypertension.-In women with a high perinatal risk on the background of the studied EGDs, the third trimester of pregnancy, despite the ongoing conventional treatment, is characterized by persistent impairment in fetoplacental blood circulation.-The inclusion of HBOT in complex therapy in the early stages of pregnancy in women with a high perinatal risk allows leveling out the inevitable disturbances in fetoplacental blood circulation on the background of the studied EGDs.
An increase in the incidence of extragenital diseases (EGDs) in the population against the background of the rise in the birth rate actualizes the problems of pregnancy management in women with EGD. Pregnancy-induced physiological changes in the body lead to a worsening of the course of diseases that were at the stage of unsustainable compensation before pregnancy. The purpose of our study was to determine the effectiveness of hyperbaric oxygenation (HBO) in the prevention of obstetric complications in pregnant women with EGD and neonatal morbidity. The inclusion of HBO in a complex of therapeutic and prophylactic measures in pregnant women with high perinatal risk contributed to a significant reduction in premature birth and a statistically significant improvement in neonatal morbidity parameters.
Premature birth (PB) is associated with placental insufficiency, which is confirmed in the morphological study of the placenta. Ultrasonic markers of placental abnormalities, often preceding PB, have been identified: changes in placental structure, premature ripening of the placenta, oligohydramnios, and fetal-placental circulation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.